Kenneth M. Cohen, President and CEO at Somaxon Pharmaceuticals, Inc. (SOMX), sold 5,000 shares at $12.55 ($63K) on 2007-04-09, disclosed to the SEC on 2007-04-09.
Scheduled sale ($63k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 200 | $3K | 4.0% |
| 2 | $12.55 | 4,800 | $60K | 96.0% |
| Total | $12.55 avg | 5,000 | $63K | 100% |
| Filing → |
| MBVX | BUY | 2014-12-18 | $5K | — | Filing → |
| MBVX | BUY | 2014-12-17 | $10K | — | Filing → |
| SOMX | SELL | 2007-04-27 | $360K | — | Filing → |